• SENSEX 78,553.20
    1,508.91 (+1.96%)
  • BANKNIFTY 54,290.20
    1,172.45 (+2.21%)

IPO

Explore our secure online trading, IPO bidding, mutual fund investments, and depository services, all designed to provide seamless transactions, expert insights, and real-time market access for smart investing

IRM Energy Ltd

IRM Energy Ltd

    Registered Office : 4th Floor Block 8 Magnet,Corporate Park S G Highway,Ahmedabad Gujarat 380054 Phone : 91-7949031500
    Fax :

    Email : investor.relations@irmenergy.com

    Website : www.irmenergy.com

Initial public offer of 10,800,000* equity shares of face value of Rs. 10 each ("Equity Shares") of the company for cash at a price of Rs. 505 per equity share (including a share premium of Rs. 495 per equity share) ("Issue Price") aggregating to Rs. 544.36 crores* (the "Issue"). The issue includes a reservation of 216,000* equity shares for subscription by eligible employees (as defined herein) ("Employee Reservation Portion"). The issue less the employee reservation portion is referred to as the "Net Issue". The company in consultation with the book running lead managers, has offered a discount 9.50% of the issue price equivalent of Rs. 48.00 per equity share to eligible employees bidding in the employee reservation portion ("Employee Discount"). The issue and the net issue shall constitute 26.30% and 25.78%, respectively, of the post-issue paid-up equity share capital of the company. The face value of the equity shares is Rs. 10 each. The issue price is Rs. 505 per equity share which is 50.5 times the face value of the equity shares. *Subject to finalisation of basis of allotment.

Issue

Opens On

Closes On

18-Oct-2023

20-Oct-2023

Money Payable On

Application

Allotment

505.00

0.00

Minimum Application for shares in Nos : 29.0 Further Multiples of : 29.0

₹Cr

Lead Managers to the Issue

Project Cost (₹.Cr)

Project Financed through Current Offer (₹.Cr)

Post Issue Equity Share Capital (₹.Cr)

Issue Price (₹.Cr)

495.86

544.36

41.06

505.00

Projects
  • Prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company
  • General Corporate Purposes
Promoted By
  • Rajiv Indravadan Modi
  • Cadila Pharmaceuticals Ltd
  • Irm Trust
Listing At
  • BSE
  • NSE
Registrar to the Issue